Scientists have found a potential target for novel therapeutic strategies to combat fungal infections caused by Aspergillus fumigatus and are now looking for a molecule that inactivates the protein expressed by the gene as a basis for a drug.
Included as a benefit
Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.
Find out more about how to join.
FREE
Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.
3.75 per month / £35 annually
Get unlimited access to The Microbiologist.